Cardiometabolic Profiles in Women with a History of Hypertensive and Normotensive Fetal Growth Restriction

2021 ◽  
Author(s):  
Rianne C. Bijl ◽  
Jérôme M.J. Cornette ◽  
Blanka Vasak ◽  
Arie Franx ◽  
A. Titia Lely ◽  
...  
Keyword(s):  
Fetal Growth ◽  
Fetal Growth Restriction ◽  
Growth Restriction ◽  
History Of

Effects of folic acid and vitamin B6 supplementation on women with hyperhomocysteinemia and a history of preeclampsia or fetal growth restriction

1998 ◽  
Vol 179 (1) ◽  
pp. 135-139 ◽  
Author(s):  
Michal Leeda ◽  
Naghmeh Riyazi ◽  
Johanna I.P. de Vries ◽  
Cornelis Jakobs ◽  
Herman P. van Geijn ◽  
...  
Keyword(s):  
Folic Acid ◽  
Fetal Growth ◽  
Fetal Growth Restriction ◽  
Vitamin B6 ◽  
Growth Restriction ◽  
History Of

scholarly journals Hepatitis E, Schistosomiasis and Echinococcosis–Prevalence in a Cohort of Pregnant Migrants in Germany and Their Influence on Fetal Growth Restriction

Pathogens ◽  
2022 ◽  
Vol 11 (1) ◽  
pp. 58
Author(s):  
Janine Zöllkau ◽  
Juliane Ankert ◽  
Mathias W. Pletz ◽  
Sasmita Mishra ◽  
Gregor Seliger ◽  
...  
Keyword(s):  
Fetal Growth ◽  
Fetal Growth Restriction ◽  
Hepatitis E ◽  
Growth Restriction ◽  
Premature Delivery ◽  
Delivery Methods ◽  
Increased Risk ◽  
History Of ◽  
Adverse Pregnancy ◽  
History Of Migration

Background: Infections, as well as adverse birth outcomes, may be more frequent in migrant women. Schistosomiasis, echinococcosis, and hepatitis E virus (HEV) seropositivity are associated with the adverse pregnancy outcomes of fetal growth restriction and premature delivery. Methods: A cohort study of 82 pregnant women with a history of migration and corresponding delivery of newborns in Germany was conducted. Results: Overall, 9% of sera tested positive for anti-HEV IgG. None of the patients tested positive for anti-HEV IgM, schistosomiasis, or echinococcus serology. Birth weights were below the 10th percentile for gestational age in 8.5% of the neonates. No association between HEV serology and fetal growth restriction (FGR) frequency was found. Conclusions: In comparison to German baseline data, no increased risk for HEV exposure or serological signs of exposure against schistosomiasis or echinococcosis could be observed in pregnant migrants. An influence of the anti-HEV serology status on fetal growth restriction could not be found.

693: Natural history of stillbirth in placenta based fetal growth restriction - Implications for surveillance

2008 ◽  
Vol 199 (6) ◽  
pp. S198 ◽  
Author(s):  
Ahmet Baschat ◽  
Christoph Berg ◽  
Ozhan Turan ◽  
Sifa Turan ◽  
Henry Galan ◽  
...  
Keyword(s):  
Natural History ◽  
Fetal Growth ◽  
Fetal Growth Restriction ◽  
Growth Restriction ◽  
History Of

FETAL GROWTH RESTRICTION WITH EARLY AND LATE MANIFESTATION, PROGNOSTIC MARKERS

2020 ◽  
pp. 27-30
Author(s):  
Yakubova D.I.
Keyword(s):  
Risk Factors ◽  
Pregnant Women ◽  
Fetal Growth ◽  
Fetal Growth Restriction ◽  
Prenatal Screening ◽  
Prognostic Markers ◽  
Growth Restriction ◽  
Late Manifestation ◽  
Late Form ◽  
Early Manifestation

Objective of the study: Comprehensive assessment of risk factors, the implementation of which leads to FGR with early and late manifestation. To evaluate the results of the first prenatal screening: PAPP-A, B-hCG, made at 11-13 weeks. Materials and Methods: A retrospective study included 110 pregnant women. There were 48 pregnant women with early manifestation of fetal growth restriction, 62 pregnant women with late manifestation among them. Results of the study: The risk factors for the formation of the FGR are established. Statistically significant differences in the indicators between groups were not established in the analyses of structures of extragenital pathology. According to I prenatal screening, there were no statistical differences in levels (PAPP-A, b-hCG) in the early and late form of FGR.

Sign in / Sign up

Export Citation Format

Share Document